All patients had angiographically confirmed CAD, had received a stable statin dose for over a month, and presented LDL-C plasma levels over 80 mg/dL or 60–80 mg/dL in the presence of either 1 major (non-coronary atherosclerotic cardiovascular disease, acute coronary syndrome, or type 2 diabetes mellitus) or 3 minor (current smoking, hypertension, low HDL-C, family history of premature CAD, age [men ≥ 50 y; women ≥ 55 y], CRP ≥ 2 mg/L) risk factors. Here, CRP is linked to coronary artery disorder.